Printer Friendly
The Free Library
14,709,857 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

House Foods, Takeda Pharmaceutical Conclude Joint Venture Agreement on Beverage and Food Businesses.


Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Feb 27, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - House Foods and Takeda Takeda (武田氏 Takeda)  Pharmaceutical have signed a joint venture agreement on their beverage and food businesses.

Under the terms of the agreement, the two companies will establish a new company, House Wellness Foods Corporation, with a capital of 100 million yen ($840,000), on April 3. House Foods will have a 66% stake in the new company while Takeda Pharmaceutical will retain the remaining 34%. After the initial 18-month joint venture period, the new company will become a wholly owned House Foods subsidiary.

House Wellness Foods Corporation will combine House Foods's proprietary food processing Food processing is the set of methods and techniques used to transform raw ingredients into food for consumption by humans or animals. The food processing industry utilises these processes.  technologies with Takeda's expertise in the development of vitamin products. It will be in charge of the core health food business of House Foods.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Mar 3, 2006
Words:135
Previous Article:CALPIS to Introduce Calorie-Free Beverage Based on Lactic Acid Bacteria in April.
Next Article:Kyowa Hakko Kogyo Begins Operations at New Plant in China.



Related Articles
Hitachi, Takeda Pharmaceutical to Establish Information System Service Joint Venture.
Takeda Pharmaceutical and House Foods Form Business Alliance.
Takeda Pharmaceutical Transfers All BASF Takeda Vitamin Shares to BASF Japan.
Takeda Starts Phase 2 Clinical Studies of ATL-962, an Obesity and Related Disease Treatment, in Japan.
FDA Approves AMITIZA, Chronic Idiopathic Constipation Agent - Sucampo and Takeda Pharmaceuticals to Begin Joint Promotion in Spring.
Takeda Pharmaceutical, Hitachi Jointly Establish New Information System Company for Medical and Pharmaceutical Businesses.
Takeda Pharmaceutical Wins Patent Infringement Case on ACTOS in US.
US District Court Dismisses Abbott Laboratories' Litigation Against Takeda Pharmaceutical.
Takeda Pharmaceutical to Obtain Exclusive Right to Develop and Market Hematide.
Takeda Pharmaceutical, Galaxy Biotech to Sign Licensing Agreement for HuL2G7, Investigational Agent for Cancer Treatment.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles